Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
Last month, the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) jointly hosted a public meeting of the interagency “Strike ...
California courts were home to the most federal trade secrets litigation over the past three years, according to a report ...
Paulick Report on MSN19h
Trainer Natalia Lynch Reinstated After Settlement Agreement With HIWUOne anti-doping charge was dropped, another reduced to 14 months after hearings in front of the FTC administrative law judge ...
More than a year ago, Buckeye Lake resident Pam Spring called Better Call 4 after she bought a pair of shoes from HeyDude.com ...
On Monday, fashion icon Michael Kors testified in an antitrust trial in Manhattan as a Federal Trade Commission lawsuit filed ...
Under the FOCAL plan, federal agencies have been urged to prioritize asset management, vulnerability management, defensible ...
Antitrust regulation isn't just about protecting consumers, Federal Trade Commission chair Lina Khan said Thursday afternoon ...
The Coach and Michael Kors case shows the limits of antitrust challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback